KOSS vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

KOSS

46.2
AI Score
VS
KOSS Wins

CLOV

44.5
AI Score

Investment Advisor Scores

KOSS

46score
Recommendation
HOLD

CLOV

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric KOSS CLOV Winner
Forward P/E 526.3158 37.7358 CLOV
PEG Ratio 0 0 Tie
Revenue Growth 5.8% 55.6% CLOV
Earnings Growth 37.1% 0.0% KOSS
Tradestie Score 46.2/100 44.5/100 KOSS
Profit Margin -3.0% -0.7% CLOV
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

KOSS 1M: -11.6% · 3M: -6.9% CLOV 1M: +3.2% · 3M: +9.1%

Current Technical Phase

KOSS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 38.5 · Price: $3.49

CLOV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.2% over 20 days), RSI 54

RSI (14): 54.3 · Price: $4.72

Fundamentals Snapshot

Metric KOSS CLOV
Market Cap — —
Forward P/E 526.3 31.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.6%
Gross Margin 0.4% 0.2%
Operating Margin -0.3% 0.0%
EPS -0.04 -0.05
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, KOSS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.